🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension

International Journal of Molecular Sciences(2022)10.3390/ijms23147680Source: DataRank Database

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A
0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations
Free full text
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Funding (2 grants)Impact (FWCI 1.08)OA: goldTopics (57)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      Authors (5)

      Martha FrancoORCID,Courtney DugasORCID,Akemi Katsurada,L. Gabriel NavarORCID,Ryousuke SatouORCID
      Live enrichment
      PubMed:35887028OpenAlex:https://openalex.org/W4285094315

      NIDDK

      Grant: R01DK107694

      National Institutes of Health

      Grant: 1R01DK107694-01

      Histone deacetylase 9 is an epigenetic suppressor of intrarenal angiotensinogen, serving as a key mechanism in angiotensinogen augmentation in hypertension

      FWCI

      1.08

      Citation Percentile

      0.8%

      Citation Trend

      2023
      2024
      2025

      goldLicense: cc-by
      journalhttps://www.mdpi.com/1422-0067/23/14/7680/pdf?version=1657614542
      publisherhttps://www.mdpi.com/1422-0067/23/14/7680/pdf?version=1657614542
      publisherhttps://www.mdpi.com/1422-0067/23/14/7680/pdf
      journalhttps://doi.org/10.3390/ijms23147680
      repositoryhttps://pubmed.ncbi.nlm.nih.gov/35887028

      Fields of Study

      Renin-Angiotensin System StudiesHormonal Regulation and HypertensionCardiovascular, Neuropeptides, and Oxidative Stress Research0301 basic medicine0303 health sciences03 medical and health sciencesAngiotensin IIAngiotensinogenAnimalsBlood PressureHypertensionImmunosuppression TherapyKidneyKidney DiseasesMycophenolic AcidProteinuriaRNA, MessengerRatsRats, Sprague-Dawley

      MeSH Terms

      Angiotensin IIAngiotensinogenAnimalsBlood PressureHypertensionImmunosuppression TherapyKidneyKidney DiseasesMycophenolic AcidProteinuriaRNA, MessengerRats, Sprague-DawleyRats

      Keywords

      MycophenolateAngiotensin IIEndocrinologyMedicineInternal medicineKidneyProteinuriaMycophenolic acidRenin–angiotensin systemImmunosuppressionUrinary systemBlood pressureUrologyTransplantationImmunosuppression Therapyhypertensionmycophenolate mofetilAngiotensinogenArticleRatsRats, Sprague-Dawleykidney injuryAnimalsKidney DiseasesRNA, Messenger

      Sustainable Development Goals

      SDG 3: 3. Good healthSDG 0: Good health and well-being